| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Renrong Wu CEO | SSE Exchange | CNE100003JD4 ISIN |
| CN Country | 673 Employees | 5 Jun 2026 Last Dividend | 28 May 2019 Last Split | - IPO Date |
Nanjing Well Pharmaceutical Group Co., Ltd., based in Nanjing, China, operates in the pharmaceutical sector with a primary focus on the research and development, production, and sale of pharmaceutical auxiliary materials within the Chinese market. Originally founded in 2000 and known as Nanjing Well Pharmaceutical Co.,Ltd., the company underwent a name change in April 2020 to better reflect its expanding portfolio and strategic direction. Its business activities extend beyond the domestic sphere as it exports products to Europe, the United States, Southeast Asia, and other international markets. Nanjing Well Pharmaceutical is uniquely positioned in the field of pharmaceuticals and specialty chemicals by providing a diversified range of products while also engaging in the manufacturing of bio-based materials, feed additives, and electronic special materials, alongside offering technical development, consultation, and services.